DR. VECIHI BATUMAN, MD
Osteopathic Medicine at Tulane Ave, New Orleans, LA
License number
Louisiana 08599R
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
1415 Tulane Ave, New Orleans, LA 70112
Phone
(504) 988-2300
(504) 988-7144 (Fax)
(504) 988-8886 (Fax)
(504) 988-7144 (Fax)
(504) 988-8886 (Fax)
Organization information
See more information about VECIHI BATUMAN at bizstanding.comVecihi Batuman MD
New Orleans, LA
Industry:
Internist
Phone:
(504) 988-5346 (Phone), (504) 988-5363 (Phone), (504) 988-2177 (Phone)
Addresses:
1430 Tulane Ave, New Orleans, LA 70112
1415 Tulane Ave, New Orleans, LA 70112
1415 Tulane Ave, New Orleans, LA 70112
Vecihi Batuman
Categories:
Nephrology Physicians & Surgeons, Physicians & Surgeons
Vecihi Batuman MD
275 Lasalle St #HC57, New Orleans, LA 70112
Categories:
Nephrology Physicians & Surgeons
Phone:
(504) 988-5030 (Phone)
Professional information
Vecihi Batuman, New Orleans LA
Specialties:
Nephrologist
Address:
1415 Tulane Ave, New Orleans, LA 70112
Education:
Hacettepe University, Faculty of Medicine - Doctor of Medicine*
Jersey City Medical Center - Fellowship - Nephrology (Internal Medicine)*
Jersey City Medical Center - Residency - Internal Medicine*
Jersey City Medical Center - Fellowship - Nephrology (Internal Medicine)*
Jersey City Medical Center - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)*
Vecihi Batuman, New Orleans LA
Specialties:
Internal Medicine, Nephrology
Work:
Tulane University
1415 Tulane Ave, New Orleans, LA 70112 Tulane University
1430 Tulane Ave, New Orleans, LA 70112 Tulane Multispecialty Clinic Downtown
275 Lasalle St, New Orleans, LA 70112 Southeast Louisiana Veterans Health Care System
1601 Perdido St, New Orleans, LA 70112
1415 Tulane Ave, New Orleans, LA 70112 Tulane University
1430 Tulane Ave, New Orleans, LA 70112 Tulane Multispecialty Clinic Downtown
275 Lasalle St, New Orleans, LA 70112 Southeast Louisiana Veterans Health Care System
1601 Perdido St, New Orleans, LA 70112
Education:
Ankara Universitesi (1972)
Dr. Vecihi Batuman - MD (Doctor of Medicine)
Hospitals:
Tulane School-Medicine Nephrlgy
1430 Tulane Ave, New Orleans 70112
Tulane University Medical Grp
275 Lasalle St, New Orleans 70112
Tulane School-Medicine Nephrlgy
1430 Tulane Ave, New Orleans 70112
Tulane University Medical Grp
275 Lasalle St, New Orleans 70112
1430 Tulane Ave, New Orleans 70112
Tulane University Medical Grp
275 Lasalle St, New Orleans 70112
Tulane School-Medicine Nephrlgy
1430 Tulane Ave, New Orleans 70112
Tulane University Medical Grp
275 Lasalle St, New Orleans 70112
Education:
Medical Schools
Hacettepe Universitesi, Tip Fakultesi
Graduated: 1972
Hacettepe Universitesi, Tip Fakultesi
Graduated: 1972
Use Of Pituitary Adenylate Cyclase-Activating Polypeptide (Pacap) And Pacap Analogs As Adjunctive Treatments With Anticancer Agents
US Patent:
2011026, Nov 3, 2011
Filed:
Sep 25, 2009
Appl. No.:
13/120862
Inventors:
Min Li - New Orleans LA, US
David H. Coy - New Orleans LA, US
Vecihi Batuman - New Orleans LA, US
David H. Coy - New Orleans LA, US
Vecihi Batuman - New Orleans LA, US
International Classification:
A61K 9/127, A61K 47/48, A61K 38/43, A61K 9/00, A61K 9/14, A61K 39/395, A61P 39/02, A61K 38/17, A61K 35/00
US Classification:
424450, 514 213, 424 7817, 424 943, 424 932, 424499, 4241781, 424400
Abstract:
This invention relates to methods and compositions for the treatment, management or prevention of injuries to one or more of the organs of the body, such as the brain, heart, lung, kidneys, liver, and gastrointestinal tract, of humans or other mammals caused by one or more anticancer agents. The methods of this invention consist of the administration of an effective amount of one or more pituitary adenylate cyclase-activating polypeptide (PACAP)-like compounds, which includes native human PACAP38, native human PACAP27, native human vasoactive intestinal peptide (VIP), their agonists, analogs, fragments, and derivatives, with activities toward one or more of the PACAP/VIP receptors, including all of their various isoforms. This invention also provides pharmaceutical compositions of one or more PACAP-like compounds of the invention either alone or in combination with one or more other prophylactic/therapeutic agents useful for the treatment, management or prevention of injuries to the organs of the body of humans or other mammals undergoing cancer chemotherapy. Combination therapy with one or more PACAP-like compounds plus one or more anticancer agents can be used in the treatment of hematological cancers.